comscore 2 models of Apple Watch can go on sale again | Honolulu Star-Advertiser
Top News

2 models of Apple Watch can go on sale again

Honolulu Star-Advertiser logo
Unlimited access to premium stories for as low as $12.95 /mo.
Get It Now
  • ASSOCIATED PRESS
                                The Apple logo is illuminated at a store in the city center of Munich, Germany, in December 2020. Two higher-end models of the Apple Watch can go on sale again after a federal court temporarily lifted a sales halt ordered by the International Trade Commission over a patent dispute.

    ASSOCIATED PRESS

    The Apple logo is illuminated at a store in the city center of Munich, Germany, in December 2020. Two higher-end models of the Apple Watch can go on sale again after a federal court temporarily lifted a sales halt ordered by the International Trade Commission over a patent dispute.

Two higher-end models of the Apple Watch can go on sale again after a federal court temporarily lifted a sales halt ordered by the International Trade Commission over a patent dispute.

The ITC, a federal agency, ordered the halt in October to block Apple from using specific technologies underpinning a blood-oxygen measurement system in its Series 9 and Ultra 2 watches. Apple has been embroiled in an intellectual property dispute with the medical technology company Masimo over those technologies.

Apple cut off online sales of the watches in the U.S. on last week just days from the Christmas holiday to comply with the ITC ruling. The court’s action will allow sales of the two Apple Watch models pending its decision on whether to also permit sales as it weighs Apple’s appeal. As of 3 p.m. Eastern Time on Wednesday, neither of the Apple Watch models in question were available at Apple’s online store.

This isn’t the first patent roadblock the Apple Watch has run into as the company morphs its watches into health-management devices. Last year, the ITC ruled that Apple had infringed on the wearable EKG technology of AliveCor — a decision the Biden administration declined to overturn. That dispute hasn’t directly affected Apple Watch sales yet because another regulatory body had ruled that AliveCor’s technology isn’t patentable. The legal tussle on that issue is still ongoing.

The patent headaches facing Apple as it tries to infuse more medical technology into its watch models make it increasingly likely the company will either have to start working out licensing deals or simply acquiring startups specializing in the field, Wedbush Securities analyst Dan Ives predicted.

Comments (2)

By participating in online discussions you acknowledge that you have agreed to the Terms of Service. An insightful discussion of ideas and viewpoints is encouraged, but comments must be civil and in good taste, with no personal attacks. If your comments are inappropriate, you may be banned from posting. Report comments if you believe they do not follow our guidelines.

Having trouble with comments? Learn more here.

Click here to see our full coverage of the coronavirus outbreak. Submit your coronavirus news tip.

Be the first to know
Get web push notifications from Star-Advertiser when the next breaking story happens — it's FREE! You just need a supported web browser.
Subscribe for this feature

Scroll Up